Objective: Aim of this paper is to present the design, construction, and modalities of dissemination of the AutoInflammatory Disease Alliance (AIDA) International Registry for patients with systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD), which are the pediatric and adult forms of the same autoinflammatory disorder. Methods: This Registry is a clinical, physician-driven, population- and electronic-based instrument implemented for the retrospective and prospective collection of real-world data. The collection of data is based on the Research Electronic Data Capture (REDCap) tool and is intended to obtain evidence drawn from routine patients' management. The collection of standardized data is thought to bring knowledge about real-life clinical research and potentially communicate with other existing and future Registries dedicated to Still's disease. Moreover, it has been conceived to be flexible enough to easily change according to future scientific acquisitions. Results: Starting from June 30th to February 7th, 2022, 110 Centers from 23 Countries in 4 continents have been involved. Fifty-four of these have already obtained the approval from their local Ethics Committees. Currently, the platform counts 290 users (111 Principal Investigators, 175 Site Investigators, 2 Lead Investigators, and 2 data managers). The Registry collects baseline and follow-up data using 4449 fields organized into 14 instruments, including patient's demographics, history, clinical manifestations and symptoms, trigger/risk factors, therapies and healthcare access. Conclusions: This international Registry for patients with Still's disease will allow a robust clinical research through collection of standardized data, international consultation, dissemination of knowledge, and implementation of observational studies based on wide cohorts of patients followed-up for very long periods. Solid evidence drawn from "real-life" data represents the ultimate goal of this Registry, which has been implemented to significantly improve the overall management of patients with Still's disease. NCT05200715 available at https://clinicaltrials.gov/.

Development and implementation of the AIDA international registry for patients with Still's disease / Vitale, Antonio; Della Casa, Francesca; Lopalco, Giuseppe; Pereira, Rosa Maria; Ruscitti, Piero; Giacomelli, Roberto; Ragab, Gaafar; La Torre, Francesco; Bartoloni, Elena; Del Giudice, Emanuela; Lomater, Claudia; Emmi, Giacomo; Govoni, Marcello; Maggio, Maria Cristina; Maier, Armin; Makowska, Joanna; Ogunjimi, Benson; Sfikakis, Petros P; Sfriso, Paolo; Gaggiano, Carla; Iannone, Florenzo; Dagostin, Marília A; Di Cola, Ilenia; Navarini, Luca; Ahmed Mahmoud, Ayman Abdelmonem; Cardinale, Fabio; Riccucci, Ilenia; Paroli, Maria Pia; Marucco, Elena Maria; Mattioli, Irene; Sota, Jurgen; Abbruzzese, Anna; Antonelli, Isabele P B; Cipriani, Paola; Tufan, Abdurrahman; Fabiani, Claudia; Ramadan, Mustafa Mahmoud; Cattalini, Marco; Kardas, Riza Can; Sebastiani, Gian Domenico; Giardini, Henrique A Mayrink; Hernández-Rodríguez, José; Mastrorilli, Violetta; Więsik-Szewczyk, Ewa; Frassi, Micol; Caggiano, Valeria; Telesca, Salvatore; Giordano, Heitor F; Guadalupi, Emmanuele; Giani, Teresa; Renieri, Alessandra; Colella, Sergio; Cataldi, Giulia; Gentile, Martina; Fabbiani, Alessandra; Al-Maghlouth, Ibrahim A; Frediani, Bruno; Balistreri, Alberto; Rigante, Donato; Cantarini, Luca. - In: FRONTIERS IN MEDICINE. - ISSN 2296-858X. - 9:(2022). [10.3389/fmed.2022.878797]

Development and implementation of the AIDA international registry for patients with Still's disease

Del Giudice, Emanuela;Paroli, Maria Pia;
2022

Abstract

Objective: Aim of this paper is to present the design, construction, and modalities of dissemination of the AutoInflammatory Disease Alliance (AIDA) International Registry for patients with systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD), which are the pediatric and adult forms of the same autoinflammatory disorder. Methods: This Registry is a clinical, physician-driven, population- and electronic-based instrument implemented for the retrospective and prospective collection of real-world data. The collection of data is based on the Research Electronic Data Capture (REDCap) tool and is intended to obtain evidence drawn from routine patients' management. The collection of standardized data is thought to bring knowledge about real-life clinical research and potentially communicate with other existing and future Registries dedicated to Still's disease. Moreover, it has been conceived to be flexible enough to easily change according to future scientific acquisitions. Results: Starting from June 30th to February 7th, 2022, 110 Centers from 23 Countries in 4 continents have been involved. Fifty-four of these have already obtained the approval from their local Ethics Committees. Currently, the platform counts 290 users (111 Principal Investigators, 175 Site Investigators, 2 Lead Investigators, and 2 data managers). The Registry collects baseline and follow-up data using 4449 fields organized into 14 instruments, including patient's demographics, history, clinical manifestations and symptoms, trigger/risk factors, therapies and healthcare access. Conclusions: This international Registry for patients with Still's disease will allow a robust clinical research through collection of standardized data, international consultation, dissemination of knowledge, and implementation of observational studies based on wide cohorts of patients followed-up for very long periods. Solid evidence drawn from "real-life" data represents the ultimate goal of this Registry, which has been implemented to significantly improve the overall management of patients with Still's disease. NCT05200715 available at https://clinicaltrials.gov/.
2022
autoinflammatory diseases; personalized medicine; precision medicine; rare diseases; research; treatment
01 Pubblicazione su rivista::01a Articolo in rivista
Development and implementation of the AIDA international registry for patients with Still's disease / Vitale, Antonio; Della Casa, Francesca; Lopalco, Giuseppe; Pereira, Rosa Maria; Ruscitti, Piero; Giacomelli, Roberto; Ragab, Gaafar; La Torre, Francesco; Bartoloni, Elena; Del Giudice, Emanuela; Lomater, Claudia; Emmi, Giacomo; Govoni, Marcello; Maggio, Maria Cristina; Maier, Armin; Makowska, Joanna; Ogunjimi, Benson; Sfikakis, Petros P; Sfriso, Paolo; Gaggiano, Carla; Iannone, Florenzo; Dagostin, Marília A; Di Cola, Ilenia; Navarini, Luca; Ahmed Mahmoud, Ayman Abdelmonem; Cardinale, Fabio; Riccucci, Ilenia; Paroli, Maria Pia; Marucco, Elena Maria; Mattioli, Irene; Sota, Jurgen; Abbruzzese, Anna; Antonelli, Isabele P B; Cipriani, Paola; Tufan, Abdurrahman; Fabiani, Claudia; Ramadan, Mustafa Mahmoud; Cattalini, Marco; Kardas, Riza Can; Sebastiani, Gian Domenico; Giardini, Henrique A Mayrink; Hernández-Rodríguez, José; Mastrorilli, Violetta; Więsik-Szewczyk, Ewa; Frassi, Micol; Caggiano, Valeria; Telesca, Salvatore; Giordano, Heitor F; Guadalupi, Emmanuele; Giani, Teresa; Renieri, Alessandra; Colella, Sergio; Cataldi, Giulia; Gentile, Martina; Fabbiani, Alessandra; Al-Maghlouth, Ibrahim A; Frediani, Bruno; Balistreri, Alberto; Rigante, Donato; Cantarini, Luca. - In: FRONTIERS IN MEDICINE. - ISSN 2296-858X. - 9:(2022). [10.3389/fmed.2022.878797]
File allegati a questo prodotto
File Dimensione Formato  
Vitale_Development and_2022.pdf

accesso aperto

Note: https://www.frontiersin.org/articles/10.3389/fmed.2022.878797/full
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 372.24 kB
Formato Adobe PDF
372.24 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1630358
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 10
social impact